Brief: Surface Oncology To Appoint Robert Ross, M.D., As President And Chief Executive Officer
11/02/2021 12:34
Feb 11 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY TO APPOINT ROBERT ROSS, M.D., AS
PRESIDENT AND
CHIEF EXECUTIVE OFFICER
* SURFACE ONCOLOGY INC - ROBERT ROSS TO SUCCEED CURRENT CEO
JEFF
GOATER, WHO WILL BECOME CHAIRMAN OF BOARD
* SURFACE ONCOLOGY INC - CEO TRANSITION EFFECTIVE APRIL 1,
2021
Source text for Eikon: ID:nGNX2x1nfb
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing